Candriam Equities L Oncology Impact C
| MVD-Fonds Rating | EDA |
|---|---|
  | 81 |
ISIN: LU1864481467 | WKN: A2PAE9
KAG: Candriam
NAV: 286,86 USD am 26.09.2024
Portfolio
Watchlist
KursalarmChart
Kennzahlen Candriam Equities L Oncology Impact C
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | -3,18% | +8,00% | +22,07% | +0,25% | +61,34% | - | +91,24% |
| Volatilität | +10,10% | +11,71% | +12,13% | +14,81% | +17,13% | - | +17,08% |
| Sharpe Ratio | -3,46 | +1,12 | +1,54 | -0,22 | +0,39 | - | +0,49 |
| Bester Monat | - | +5,66% | +9,13% | +9,13% | +12,05% | - | +12,05% |
| Schl. Monat | - | -3,67% | -6,44% | -10,56% | -10,56% | - | -10,56% |
| Max. Verlust | -4,24% | -6,41% | -7,66% | -26,46% | -26,57% | - | -26,57% |
Monatsperformance Candriam Equities L Oncology Impact C
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Januar | +1,28% | +2,07% | -10,56% | +0,48% | -1,53% |
| Februar | +4,06% | -3,95% | -1,82% | -4,26% | -5,41% |
| März | +1,42% | +1,30% | +4,57% | -0,16% | -3,15% |
| April | -3,46% | +2,75% | -5,93% | +2,26% | +12,05% |
| Mai | +2,39% | -2,64% | -1,41% | +0,10% | +8,47% |
| Juni | +1,11% | +0,00% | -0,03% | +3,44% | +1,35% |
| Juli | +5,66% | +0,81% | +4,29% | -1,04% | +4,36% |
| August | +4,09% | -2,10% | -3,22% | +5,49% | +2,08% |
| September | -3,67% | -5,32% | -4,79% | -3,84% | +3,45% |
| Oktober | - | -6,44% | +6,96% | +3,30% | -2,27% |
| November | - | +9,13% | +5,99% | -6,45% | +5,74% |
| Dezember | - | +5,65% | -3,52% | +3,90% | +3,79% |
| Gesamt | +13,18% | +0,14% | -10,52% | +2,50% | +31,35% |
